clopidogrel/acetylsalicylic acid teva
teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinations - clopidogrel/acetylsalicylic acid teva is indicated for the prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa). clopidogrel/acetylsalicylic acid teva is a fixed‑dose combination medicinal product for continuation of therapy in:non‑st segment elevation acute coronary syndrome (unstable angina or non‑q‑wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy
clopidogrel / acetylsalicylic acid mylan
mylan pharmaceuticals limited - acetylsalicylic acid, clopidogrel hydrogen sulfate - acute coronary syndrome; myocardial infarction - antithrombotic agents - clopidogrel/acetylsalicylic acid mylan is indicated for the secondary prevention of atherothrombotic events in adult patients already taking both clopidogrel and acetylsalicylic acid (asa).clopidogrel/acetylsalicylic acid mylan is a fixed-dose combination medicinal product for continuation of therapy in:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction) including patients undergoing a stent placement following percutaneous coronary interventionst segment elevation acute myocardial infarction in medically treated patients eligible for thrombolytic therapy
clopidogrel/acetylsalicylic acid zentiva (previously duocover)
sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antithrombotic agents - acute coronary syndromemyocardial infarction
granupas (previously para-aminosalicylic acid lucane)
eurocept international b. v. - para-aminosalicylic acid - tuberculosis - antimycobacterials - granupas is indicated for use as part of an appropriate combination regimen for multi-drug resistant tuberculosis in adults and paediatric patients from 28 days of age and older when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see section 4.4).consideration should be given to official guidance on the appropriate use of antibacterial agents.
salicylic acid
vetsense pty ltd - salicylic acid - unknown - salicylic acid phenol active 0.0 - active constituent
salicylic acid ointment
syntenza pharmaceuticals llc - salicylic acid (unii: o414pz4lpz) (salicylic acid - unii:o414pz4lpz) - an external treatment for the inflammation and irritation associated with many common forms of dermatitis, including certain eczematoid conditions. these conditions include complications associated with pyodermas. indicated also in the treatment of insect bites, burns and fungal infections. salicylic acid 3% topical ointment is contraindicated for use in those patients who are hypersensitive to topical polyethylene glycols. safety and effectiveness in pediatric patients has not been established.
cartia
padagis israel agencies ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
micropirin 75
dexcel ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 75 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
micropirin 100
dexcel ltd, israel - acetylsalicylic acid - tablets enteric coated - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
aspirin c
bayer israel ltd - acetylsalicylic acid; ascorbic acid - tablets effervescent - acetylsalicylic acid 400 mg; ascorbic acid 240 mg - acetylsalicylic acid - acetylsalicylic acid - pain relief, fever reduction, antirheumatic treatment.